Which funding round is your company ready for?

Which funding round is your company ready for?

Founders often ask whether they are "a seed company" or "a Series A company" as if the answer were printed on the round. It is not. Round names are labels, often attached after the event. What decides which investors will take your call is evidence: how much risk you have already removed from the business, and how much is left.

This guide is a self-assessment: the signals investors use to place a company, as questions you can answer honestly, plus what to do between stages and why raising the wrong round is costly. For what each round is and how it is structured, read Funding rounds explained; this guide asks which one fits you.

Stages are judged on evidence, not labels

Beauhurst, whose UK data underpins the British Business Bank's Small Business Equity Tracker 2026, places companies at seed, venture or growth stage using indicators including product development, commercialisation, sales and profitability, rather than the type of round alone. In the tracker's definitions:

• a seed-stage company is young, with a small team, low valuation and some uncertainty about product-market fit;
• a venture-stage company has existed for a few years and is gaining significant market traction;
• a growth-stage company is more developed, with substantial revenue streams, some of which may be profitable.

In the US, the PitchBook-NVCA Venture Monitor (Q2 2026) tags a round as pre-seed if the company is under two years old and the round is its first institutional investment, unless the investors or the press release say otherwise.

Nor is there a revenue figure that unlocks a round. Carta, summarising Silicon Valley Bank's State of the Markets report for H1 2026, noted that US tech companies had closed seed rounds with anything from zero to $3.6 million of annual recurring revenue (ARR). If someone tells you a round "needs" a set revenue number, they are quoting a rule of thumb, not a rule.

What stays constant is the investor's question: what has this company already proved, and what is it asking me to fund it to prove next?

The six signals investors read

Work through these with a co-founder, or an adviser who will be blunt. Answer from evidence you could put in a data room, not from plans.

Team

• Can the founders between them build the product and sell it, or is one still missing?
• Have you worked together before, ideally under pressure?
• Is the next critical hire (a sales lead, a regulatory lead, an engineering manager) identified or already in post?
• Is founder equity settled and documented, with vesting?

Product

• Can a customer use something today, or is it still a design, prototype or pilot?
• In regulated or technical fields: which technical, trial or approval milestones are done, and which remain?

Customers and revenue

• How many customers or users do you have who are not friends, family or unpaid pilots?
• Are they paying, and would they notice if the product disappeared tomorrow?
• Is revenue recurring, contracted or one-off?
• How many customers came through a channel you could repeat, rather than a founder's personal network?

Growth

• What is the month-by-month trend, over at least six months, in the one number that best measures your progress?
• Does growth come from a channel you can put more money into, or from one-off events?
• Do customers stay and spend more over time?

Unit economics

• Do you know what it costs to win a customer and what that customer is worth over their lifetime?
• Does each sale make money after direct costs, or lose it?
• How many months of cash do you have at your current burn rate?

Market

• Can you size the market from the bottom up (number of buyers multiplied by what they would pay), not just quote an industry report?
• Why now: what has changed that makes this possible or urgent?
• Who else is solving the problem, and why do customers choose you?

Answers tend to cluster. Mostly "not yet" means you are raising to find out whether the idea works; mostly "yes, and here is the data" means the conversation is about how fast it can grow. Place yourself where most answers sit, not where your best one sits.

What each round is usually buying

Each round funds the removal of a particular kind of risk. The medians below describe the middle of very wide ranges; Carta itself calls such figures a guideline only, and every deal differs.

Pre-seed: proof that the problem and the team are real

At pre-seed, investors mostly back people and a problem. A prototype, a waiting list, letters of intent or a few design partners all help. Y Combinator's guide to seed fundraising describes the underlying test: investors commit when the idea is compelling, the founders look able to realise it, and the opportunity seems real and large enough.

Rounds are small and usually unpriced. Carta's State of Pre-Seed report for Q2 2026 counted $3.19 billion raised by US startups across more than 11,500 pre-seed SAFEs and convertible notes, an average of $276,000 per instrument, and noted that few pre-seed deals exceed $2.5 million. In the UK, many first rounds are built around the Seed Enterprise Investment Scheme. The gov.uk SEIS guidance caps what a company can receive under SEIS at £250,000, with gross assets of no more than £350,000 and fewer than 25 full-time equivalent employees when the shares are issued, and a qualifying trade no more than three years old.

Seed: proof that customers want it

A seed investor wants the product in use and early signs of pull: paying customers, strong engagement, or pilots turning into contracts. You do not need a repeatable sales engine yet, but you should be able to say what the money will let you test.

In Carta's July 2026 benchmarks, covering US software companies' rounds in the previous six months and excluding bridges and extensions, the median seed round raised $4.1 million at a median valuation of $24.3 million, with median dilution of 18%. In the UK, the British Business Bank tracker reports that the median deal for seed-stage companies in 2025 was £0.6 million at a median pre-money valuation of £3.2 million.

Series A: proof that growth is repeatable

Series A investors want to see that something works and that putting money into it produces predictable growth: a channel that brings in customers at a known cost, customers who stay, improving unit economics, and a team that can scale.

The step up is steep. In Carta's reading of the SVB data (H1 2026), median revenue at Series A was 11.3 times median revenue at seed. Carta's July 2026 software benchmarks put the median Series A at $14.4 million raised at an $80 million valuation, again with 18% dilution. The UK tracker's nearest category, venture stage, had a 2025 median deal of £1.1 million at an £8.2 million pre-money valuation (a Beauhurst stage is not the same as a US Series A).

Series B and later: proof that the model scales

By Series B, investors are funding expansion (new markets, new products, a larger organisation) on the back of a model that already works. Efficiency and the depth of the management team beyond the founders matter more. Carta's July 2026 median Series B raised $25 million at a $191 million valuation, selling about 12% of the company. The UK tracker's growth-stage median deal in 2025 was £2.6 million at a £22.3 million pre-money valuation.

Checklist by stage

A summary of common expectations, not thresholds: a company can raise with gaps if the rest of its evidence is strong.

Signal	Pre-seed	Seed	Series A	Series B and later
Team	Founders can build and sell, or plan how to	Core team in place; first hires made	Sales, product and engineering leads hired or identified	Management team beyond the founders; a working board
Product	Prototype, pilot or clear design	Live product in regular use	Product customers rely on; roadmap led by usage data	Stable product, possibly several; ready for new markets
Customers and revenue	Interviews, waiting list, letters of intent	First paying customers or strong usage	Recurring revenue from customers won through repeatable channels	Substantial revenue across segments; some parts may be profitable
Growth	Not expected	An early trend, month on month	Consistent growth over several quarters	Growth sustained at a larger scale
Unit economics	A hypothesis	First estimates of acquisition cost and customer value	Measured and improving	Proven by segment; a visible path to profitability
Market	Problem and buyer defined	Bottom-up sizing and a "why now"	Evidence the market can support a large outcome	Room to expand into adjacent markets
What the money buys	Proof of the problem and a first version	Product-market fit	Scaling what works	Expansion and defence

If you fall between two stages

Being between stages is normal, and it can last. The British Business Bank tracker found that the median time between rounds for UK seed-stage companies rose to 14.4 months in 2025, from 12.4 months in 2024. In the US, Carta reported a median interval of 616 days between seed and Series A in Q2 2025, a little over 20 months. Carta's March 2026 benchmark for seed funds treats about a quarter of seed companies reaching Series A within two years as a middling result, and 35% as high.

Extend the current round

Add money on the same or similar terms, usually from existing investors. It is faster than a new round but not free. Carta's February 2025 look at dilution found that a bridge or extension typically comes in at about half the equity of the original round: a seed that sold 20% can be followed by an extension selling another 10%.

Bridge to a named milestone

A bridge, often a SAFE or convertible note, should fund one specific proof point: a launch, a signed contract, a regulatory step. Name the milestone and the date before you ask. A bridge without one is only a slower way to run out of cash.

Raise less, for a shorter plan

Y Combinator's guide advises companies that will need a follow-on round to raise enough to reach their next "fundable" milestone, usually 12 to 18 months away, and to tie the amount to a believable plan, with versions for different amounts raised. A smaller round that matches your evidence is usually easier to close than a large one at a price the evidence cannot support.

Use non-dilutive money to reach the next proof point

Grants such as Innovate UK programmes, R&D tax relief, the US SBIR programme, customer prepayments or debt can close a gap without selling equity. Carta's State of Private Markets for Q1 2026 observed that non-dilutive debt was letting hardware founders build before raising, arriving at institutional rounds with less dilution. Ways to fund a company compares these routes; Should you raise money at all? covers not raising.

Why raising "the wrong round" hurts

Raising too much, too early, at too high a price

The price you set becomes the bar for your next round. The PitchBook-NVCA Venture Monitor (Q2 2026) warns that companies which raised at elevated prices on compressed timelines need to show fast growth to raise again, or they risk a down round. Carta put the down-round rate among companies on its platform at 11.4% in Q1 2026, back to 2019 and 2020 levels, but a down round still hurts: it signals trouble, can leave employee options worth less than their exercise price and, if earlier investors hold anti-dilution protection, shifts more of the cost onto founders.

Worked example (an illustration, not market data). Two companies each sell 20% at seed, then raise £2 million at a £6 million pre-money valuation 18 months later.

• Company A raised £1.5 million at a £6 million pre-money valuation (£7.5 million post-money). Its next round, at £6 million pre-money, prices the company below the £7.5 million it was worth after the seed round: a down round of 20% on price.
• Company B raised £750,000 at a £3 million pre-money valuation (£3.75 million post-money). The same next round is an up round, with a price 60% higher than at seed.

In both cases the new investors take 25% (£2 million of £8 million post-money) and the founders fall from 80% to 60%, before any anti-dilution adjustment. The stake is the same, but Company A now has a down round on its record, while Company B shows steady progress.

Raising too little, too late

Starting a round with a few months of cash left weakens your hand: investors can see the deadline. Plan for the median intervals above, not the fastest cases you read about.

Pitching the wrong investors

A fund that invests at Series A is unlikely to lead a pre-seed round, and each mismatched meeting costs time. Match investors to your stage, for example through our lists of pre-seed investors and seed-stage investors. Be careful, too, with headline valuations: the Venture Monitor notes that a post-money valuation reflects the top price in a round, not what every investor paid.

In the UK, taking scheme money in the wrong order

The gov.uk guidance says a company cannot use SEIS once it has received investment through the Enterprise Investment Scheme or from a venture capital trust. The EIS guidance, updated on 6 April 2026, lets most companies raise up to £10 million in any 12 months and £24 million in their lifetime from the venture capital schemes, within seven years of their first commercial sale; knowledge-intensive companies have different limits. If you might qualify for SEIS, use it before you accept EIS money.

How the bar differs between markets and sectors

UK and US

The same label buys very different amounts in the two markets, although the data sets above define stages differently and are not like-for-like. The British Business Bank tracker found that UK venture capital investment averaged 0.60% of GDP over 2023 to 2025, against 0.79% in the US. It also found UK seed-stage deal numbers fell 27% in 2025 while investment held at £2.1 billion: capital went to fewer companies, with more scrutiny of revenue and profitability.

In the US, the Venture Monitor estimates 5,674 first-time financings in H1 2026, on pace for a record of more than 10,000 companies raising a first venture round this year, and says median pre-money valuations have passed their 2021 highs at every series.

Benchmark against the market you are raising in. Our guides to startup funding in the UK and in the US cover each market in more depth.

Other markets

Investor bases, government programmes and typical round sizes differ again elsewhere, so read local data before borrowing any benchmark. See our country guides for India, Pakistan, the UAE and Saudi Arabia.

Sector

• AI. Carta's Q1 2026 report put the median Series A valuation for AI foundation model companies at $300 million, against $55 million for non-AI companies. AI took 86% of US venture dollars in H1 2026, according to the Venture Monitor, and 44% of investment into UK smaller businesses in 2025, according to the tracker. If you are not an AI company, do not judge your stage by AI headlines; if you are, the tracker suggests investors separate frontier model development from peripheral applications.
• Life sciences and deep tech. The tracker describes a longer path to market, driven by milestones such as prototyping, trials, regulatory approvals and specialist equipment, with costs arriving in large steps rather than rising steadily. Early revenues may be too uncertain to fund the next stage, so such companies are judged on milestones rather than sales.
• Hardware. Besides the debt pattern noted above, Carta's 2025 dilution analysis noted that hardware founders' dilution is a bit worse than software founders'.
• Software. Revenue, retention and growth efficiency dominate, and many benchmarks, including Carta's July 2026 figures above, cover software only.

Putting it together

1. Answer the six sets of questions in writing, with evidence for each answer.
2. Place yourself where most answers sit, and name the one milestone the next round must buy.
3. Size the round to that milestone, with a version of the plan for a smaller amount.
4. Build a stage-matched investor list, using our pre-seed and seed-stage lists or programmes for Series A companies.
5. Prepare your pitch deck and check your data room readiness.
6. When you are ready, publish your raise anonymously on the TrustList fundraise board, where investors can ask for an introduction.

For the full process, read How to raise money for a startup.

About this guide: general information only, not financial, legal or tax advice. TrustList does not arrange or advise on investments. Figures are from the sources linked, for the periods stated, and were checked on 26 September 2026.